GO:1990662 S100A9 complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990662 (S100A9 complex) is a cellular component defined as a protein complex composed of an S100A9 dimer that binds TLR4 and RAGE, initiates NF-kappa-B signaling, transports arachidonic acid to NADPH oxidase in neutrophils, and interacts with microtubules to promote motility.
• The S100A9 complex is a key alarmin mediator in inflammation, sepsis, cancer, and autoimmune diseases, often functioning as part of the S100A8/A9 heterodimer (calprotectin).
• S100A9 signaling through TLR4 and RAGE activates NF-kappa-B, driving pro-inflammatory cytokine production and immune cell recruitment.
• In neutrophils, the S100A9 complex facilitates arachidonic acid transport to the NADPH oxidase complex, contributing to oxidative burst and pathogen killing.
• S100A9 complex is implicated in melanoma immunosuppression, sepsis-induced endothelial damage, cardiac ischemia/reperfusion injury, and acute kidney injury [1,2,4,8].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential to dissect S100A9 complex function in disease and to validate therapeutic targets.
Description
The S100A9 complex (GO:1990662) is a cellular component defined by the Gene Ontology as a protein complex composed of an S100A9 dimer that binds to toll-like receptor 4 (TLR4) and the receptor for advanced glycation end products (RAGE), initiating signal transduction through NF-kappa-B pathways. This complex also transports arachidonic acid between the cytosol and the NADPH oxidase complex at the plasma membrane in neutrophils, contributing to an inflammatory signal cascade that leads to oxidative burst. Additionally, it interacts with microtubules to increase cell motility. S100A9 is a member of the S100 family of calcium-binding proteins and is often found as a heterodimer with S100A8, forming calprotectin, a well-established biomarker of inflammation. The S100A9 complex is a critical mediator of innate immune responses and has been implicated in a wide range of pathological conditions, including cancer, sepsis, cardiovascular disease, and autoimmune disorders [1,2,4,8]. Understanding its structure, regulation, and function is therefore of high biomedical importance.
S100A9 complex At A Glance
| GO ID | GO:1990662 |
|---|---|
| GO term | S100A9 complex |
| Ontology | cellular_component |
| Synonym | S100A9 homodimer |
| Major function | Binds TLR4 and RAGE to initiate NF-kappa-B signaling; transports arachidonic acid to NADPH oxidase; interacts with microtubules to increase motility |
| Complex composition | Homodimer of S100A9 |
| Receptor targets | TLR4, RAGE |
| Downstream pathways | NF-kappa-B signaling, oxidative burst |
| Cellular localization | Cytosol, plasma membrane, microtubules |
What Is GO:1990662?
GO:1990662 (S100A9 complex) is a protein complex that consists of a homodimer of the S100A9 protein. It is capable of binding to TLR4 and RAGE, thereby initiating signal transduction through NF-kappa-B pathways. In neutrophils, it transports arachidonic acid between the cytosol and the NADPH oxidase complex at the plasma membrane as part of an inflammatory cascade leading to oxidative burst. The complex also associates with microtubules to enhance cell motility. Its synonym is S100A9 homodimer.
Why Is S100A9 complex Important in Cell Biology?
The S100A9 complex is a central alarmin mediator that bridges innate immune sensing and inflammatory amplification. Its ability to activate TLR4 and RAGE places it at the forefront of sterile and infectious inflammation, making it a key player in diseases such as sepsis, cancer, and ischemia-reperfusion injury [1,2,4]. Moreover, its role in transporting arachidonic acid to the NADPH oxidase complex highlights its direct contribution to oxidative burst in neutrophils, a fundamental antimicrobial mechanism. Because S100A9 is secreted and can act on multiple cell types, it is an attractive biomarker and therapeutic target. Research into its complex assembly, regulation, and downstream effects is therefore critical for developing new interventions.
• Acts as a danger-associated molecular pattern (DAMP) in inflammation and sepsis.
• Promotes tumor progression and immunosuppression in melanoma through TLR4 signaling.
• Mediates cardiac ischemia/reperfusion injury via mitochondrial dysfunction.
• Drives endothelial PANoptosis in sepsis.
• Serves as a biomarker for inflammatory conditions such as atopic dermatitis.
• Contributes to brain metastasis from lung adenocarcinoma.
• Involved in bone marrow fibrosis via alarmin axis.
• Target in acute kidney injury through inflammatory macrophage subsets.
• Facilitates neutrophil oxidative burst and pathogen killing.
• Potential therapeutic target for anti-inflammatory drug development.
Structure and Composition of S100A9 complex
S100A9 homodimer assembly
In simple terms: Two S100A9 proteins join together to form the core of this complex.
The S100A9 complex is defined as a homodimer of S100A9, a calcium-binding protein of the S100 family. S100A9 can also form heterodimers with S100A8, known as calprotectin, but the GO term specifically refers to the S100A9 homodimer. The dimerization is mediated by hydrophobic and electrostatic interactions, and calcium binding induces conformational changes that expose target-binding sites.
Interaction with TLR4 and RAGE
In simple terms: The S100A9 dimer binds to two receptors on the cell surface to trigger inflammation.
The S100A9 complex binds to toll-like receptor 4 (TLR4) and the receptor for advanced glycation end products (RAGE), initiating signal transduction through NF-kappa-B pathways. This binding is a key step in the inflammatory cascade, leading to the production of pro-inflammatory cytokines and chemokines.
Arachidonic acid transport to NADPH oxidase
In simple terms: The complex carries a fatty acid molecule to the enzyme that produces reactive oxygen species.
In neutrophils, the S100A9 complex transports arachidonic acid between the cytosol and the NADPH oxidase complex at the plasma membrane as part of an inflammatory signal cascade leading to an oxidative burst. This transport is essential for the assembly and activation of the NADPH oxidase complex, which generates superoxide radicals to kill pathogens.
Association with microtubules
In simple terms: The complex binds to the cell's skeleton to help the cell move.
The S100A9 complex interacts with microtubules to increase cell motility. This interaction is thought to modulate cytoskeletal dynamics, facilitating the migration of neutrophils and other immune cells to sites of inflammation.
Key Genes Involved in GO:1990662 S100A9 complex
The following genes and proteins are directly or indirectly involved in the S100A9 complex and its signaling pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| S100A9 | Forms the homodimer; binds TLR4/RAGE; transports arachidonic acid | Core component of GO:1990662; target for knockout and overexpression studies |
| S100A8 | Forms heterodimer with S100A9 (calprotectin); modulates function | Often co-expressed; relevant for complex assembly studies |
| TLR4 | Receptor for S100A9 complex; activates NF-kappa-B | Key mediator of inflammatory signaling; knockout models available |
| RAGE | Receptor for S100A9 complex; activates NF-kappa-B | Implicated in chronic inflammation and cancer |
| NFKB1 | Transcription factor downstream of TLR4/RAGE | Central to inflammatory gene expression; point mutation models |
| CYBB | NADPH oxidase subunit; receives arachidonic acid | Oxidative burst; knockout models for neutrophil function |
| NCF1 | NADPH oxidase subunit; regulates assembly | Mutations cause chronic granulomatous disease |
| TUBB | Microtubule component; interacts with S100A9 complex | Cell motility; tagged knock-in for imaging |
| HMGB1 | Alarmin that cooperates with S100A9 in TLR4 signaling | Synergistic effects in melanoma immunosuppression |
| IL6 | Pro-inflammatory cytokine induced by NF-kappa-B | Readout of S100A9 complex activation |
| TNF | Pro-inflammatory cytokine induced by NF-kappa-B | Readout of S100A9 complex activation |
| CXCL8 | Chemokine induced by NF-kappa-B | Neutrophil recruitment; biomarker |
| CD14 | Co-receptor for TLR4 | Enhances S100A9 complex signaling |
| LY96 | MD-2, co-receptor for TLR4 | Required for TLR4 activation by S100A9 |
| ITGAM | Integrin involved in neutrophil adhesion | Modulates motility in conjunction with S100A9 complex |
| RAC1 | Small GTPase regulating NADPH oxidase | Required for oxidative burst |
| MAPK1 | Kinase downstream of TLR4/RAGE | Inflammatory signaling; point mutation studies |
| RELA | NF-kappa-B subunit | Transcription factor; knockout models |
How Is S100A9 complex Regulated?
The S100A9 complex is regulated at multiple levels. Its expression is induced by pro-inflammatory stimuli such as LPS and cytokines, and its secretion is dependent on microtubule networks. Calcium binding to S100A9 induces conformational changes that regulate its interaction with TLR4 and RAGE. Post-translational modifications, including phosphorylation and oxidation, can modulate its activity. Additionally, the complex's function in arachidonic acid transport is regulated by the availability of arachidonic acid and the assembly state of the NADPH oxidase complex. In disease contexts, S100A9 expression is often upregulated, as seen in melanoma and sepsis [1,2].
S100A9 complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| S100A9 | Melanoma immunosuppression | S100A9 knockout melanoma cells; TLR4 signaling assays |
| S100A9 | Sepsis-induced endothelial PANoptosis | Endothelial cell-specific S100A9 overexpression; mitochondrial function assays |
| S100A9 | Cardiac ischemia/reperfusion injury | Cardiomyocyte-specific S100a8/a9 knockout mice |
| S100A9 | Acute kidney injury | Macrophage-specific S100A9 knockout; kidney injury models |
| S100A9 | Myelofibrosis | Bone marrow stromal cell S100A9 knockdown; fibrosis models |
S100A9 complex in cancer and immunosuppression
S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling. The S100A9 complex activates NF-kappa-B in myeloid-derived suppressor cells, promoting an immunosuppressive tumor microenvironment. In brain metastasis from lung adenocarcinoma, single-cell transcriptomics has identified S100A9 as a driver of metastatic progression. These findings highlight the S100A9 complex as a potential target for cancer immunotherapy.
S100A9 complex in sepsis and endothelial dysfunction
S100A8/A9(hi) neutrophils induce mitochondrial dysfunction and PANoptosis in endothelial cells via mitochondrial complex I deficiency during sepsis. The S100A9 complex contributes to this process by activating TLR4 and RAGE, leading to NF-kappa-B activation and inflammatory damage. Targeting the S100A9 complex may mitigate sepsis-induced organ failure.
S100A9 complex in cardiovascular and kidney injury
S100a8/a9 signaling causes mitochondrial dysfunction and cardiomyocyte death in response to ischemic/reperfusion injury. In acute kidney injury, a unique inflammatory macrophage subset expressing S100A9 has been identified as a druggable target. These studies demonstrate the broad impact of the S100A9 complex on sterile inflammation.
S100A9 complex in chronic inflammation and fibrosis
Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis involving S100A9. In atopic dermatitis, single-cell transcriptomics combined with interstitial fluid proteomics has defined cell type-specific immune regulation, with S100A9 as a key mediator. Calprotectin (S100A8/A9) is a well-established biomarker in inflammatory bowel disease and other chronic inflammatory conditions.
From S100A9 complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does S100A9 homodimer formation require calcium? | Point mutation of calcium-binding residues; native PAGE |
| What is the role of S100A9 in TLR4 activation? | S100A9 knockout cells; NF-kappa-B reporter assays |
| How does S100A9 complex affect neutrophil oxidative burst? | Neutrophil-specific S100A9 knockout; NADPH oxidase activity assays |
| Does S100A9 complex interact with microtubules? | Tagged knock-in of S100A9 with fluorescent protein; live-cell imaging |
| What is the impact of S100A9 overexpression in tumors? | S100A9 overexpression in melanoma cells; syngeneic mouse models |
| Can S100A9 complex be targeted to reduce inflammation? | Knock-in of mutant S100A9 unable to bind TLR4; sepsis models |
How to Study the S100A9 complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Immunoprecipitation + MS | Protein interactions and complex composition | Identifying S100A9 binding partners |
| Single-cell RNA-seq | Cell type-specific expression | Mapping S100A9 expression in tissues [5,6,8] |
| NF-kappa-B reporter assay | TLR4/RAGE signaling activation | Functional validation of S100A9 complex |
| Oxidative burst assay | NADPH oxidase activity | Neutrophil function |
| Live-cell imaging | Subcellular localization and motility | Microtubule interaction |
| CRISPR knockout | Gene function loss | Target validation in disease models |
| Proximity ligation assay | In situ protein-protein interactions | TLR4-S100A9 binding |
| Calcium-binding assays | Conformational changes | S100A9 dimerization |
Proteomic and interactomic approaches
Mass spectrometry-based proteomics can identify S100A9 complex components and interacting partners. Immunoprecipitation of S100A9 followed by LC-MS/MS has been used to map the interactome in neutrophils and cancer cells. Cross-linking mass spectrometry can reveal the dimer interface and conformational changes upon receptor binding.
Transcriptomic and single-cell analysis
Single-cell RNA sequencing has been instrumental in identifying cell types that express S100A9 and its receptors in diseases such as atopic dermatitis, brain metastasis, and acute kidney injury [5,6,8]. These studies reveal heterogeneity in S100A9 expression and co-expression with inflammatory genes.
Functional assays for oxidative burst and motility
Neutrophil oxidative burst can be measured using chemiluminescence or dihydrorhodamine 123 oxidation. Cell motility assays, such as transwell migration and live-cell imaging, assess the role of S100A9 complex in microtubule-dependent movement.
Imaging and localization studies
Fluorescence microscopy with tagged S100A9 (e.g., GFP knock-in) allows visualization of complex localization to the plasma membrane, cytosol, and microtubules. FRET-based sensors can detect interactions with TLR4 and RAGE in live cells.
How CRISPR Can Be Used to Study GO:1990662 S100A9 complex
Knockout
CRISPR knockout of S100A9 in cell lines (e.g., melanoma, neutrophils) abolishes S100A9 complex formation and downstream TLR4/RAGE signaling. This is used to validate its role in immunosuppression, oxidative burst, and motility [1,3].
Point Mutation
Point mutations in S100A9 calcium-binding sites or receptor-binding interfaces can be introduced to dissect specific functions. For example, mutating the TLR4-binding region prevents NF-kappa-B activation without affecting dimerization.
Knock-in
Knock-in of tagged S100A9 (e.g., GFP, HA) allows tracking of the complex in live cells and tissues. Knock-in of disease-associated variants can model human conditions.
Overexpression
Overexpression of S100A9 in cancer cells or endothelial cells enhances complex formation and amplifies inflammatory signaling, mimicking pathological states such as sepsis or tumor progression [1,2].
How EDITGENE Supports S100A9 complex Research
Researchers studying S100A9 complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, signaling, or disease progression. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for S100A9 complex research.
Frequently Asked Questions About S100A9 complex
What is the S100A9 complex?
The S100A9 complex (GO:1990662) is a protein complex composed of an S100A9 dimer that binds TLR4 and RAGE, activates NF-kappa-B, transports arachidonic acid to NADPH oxidase, and interacts with microtubules to increase cell motility [1,3].
What genes are involved in the S100A9 complex?
The core gene is S100A9. Other key genes include S100A8, TLR4, RAGE, NFKB1, CYBB, NCF1, and TUBB, which are involved in complex formation, signaling, and downstream effects [1,3].
What is the function of S100A9 complex in neutrophils?
In neutrophils, the S100A9 complex transports arachidonic acid to the NADPH oxidase complex, leading to oxidative burst, and interacts with microtubules to enhance motility.
How is S100A9 complex involved in cancer?
S100A9 complex promotes immunosuppression in melanoma through TLR4 signaling and is associated with brain metastasis from lung adenocarcinoma [1,6].
What diseases are associated with S100A9 complex?
It is implicated in sepsis, melanoma, cardiac ischemia/reperfusion injury, acute kidney injury, myelofibrosis, and atopic dermatitis [1,2,4,5,7,8].
What is the difference between S100A9 homodimer and calprotectin?
Calprotectin is a heterodimer of S100A8 and S100A9, while the S100A9 complex (GO:1990662) specifically refers to the S100A9 homodimer.
How can I study S100A9 complex using CRISPR?
You can use CRISPR knockout, point mutation, knock-in, or overexpression to dissect S100A9 complex function in inflammation, cancer, and immune cell biology [1,3].
What are the receptors for S100A9 complex?
The S100A9 complex binds to toll-like receptor 4 (TLR4) and the receptor for advanced glycation end products (RAGE).
What signaling pathway does S100A9 complex activate?
It activates NF-kappa-B signaling pathways, leading to pro-inflammatory gene expression.
Where is S100A9 complex localized in the cell?
It is found in the cytosol, at the plasma membrane (interacting with NADPH oxidase), and associated with microtubules.
Conclusion
The S100A9 complex (GO:1990662) is a critical mediator of inflammation and immune regulation, with diverse roles in infection, cancer, and tissue injury. Its ability to activate TLR4/RAGE signaling, transport arachidonic acid, and modulate motility makes it a central node in innate immunity. Continued research using CRISPR-based models will uncover new therapeutic opportunities for inflammatory diseases.
References
- 1. Özbay Kurt FG et al.. 2024. S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling.. J Immunother Cancer 12(9) PMID: 39266214
- 2. Wang Y et al.. 2024. S100A8/A9(hi) neutrophils induce mitochondrial dysfunction and PANoptosis in endothelial cells via mitochondrial complex I deficiency during sepsis.. Cell Death Dis 15(6):462 PMID: 38942784
- 3. Jukic A et al.. 2021. Calprotectin: from biomarker to biological function.. Gut 70(10):1978-1988 PMID: 34145045
- 4. Li Y et al.. 2019. S100a8/a9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic/Reperfusion Injury.. Circulation 140(9):751-764 PMID: 31220942
- 5. Rojahn TB et al.. 2020. Single-cell transcriptomics combined with interstitial fluid proteomics defines cell type-specific immune regulation in atopic dermatitis.. J Allergy Clin Immunol 146(5):1056-1069 PMID: 32344053
- 6. Wang Z et al.. 2023. Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma.. Neuro Oncol 25(7):1262-1274 PMID: 36656750
- 7. Leimkühler NB et al.. 2021. Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis.. Cell Stem Cell 28(4):637-652.e8 PMID: 33301706
- 8. Yao W et al.. 2022. Single Cell RNA Sequencing Identifies a Unique Inflammatory Macrophage Subset as a Druggable Target for Alleviating Acute Kidney Injury.. Adv Sci (Weinh) 9(12):e2103675 PMID: 35112806
